Bio-Techne Corp (TECH) — DEF 14A Filings
All DEF 14A filings from Bio-Techne Corp. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Bio-Techne Navigates Headwinds with 5% Organic Growth, Strategic Divestitures
— Sep 19, 2025 Risk: medium
BIO-TECHNE Corp (TECH) achieved $1.2196 billion in total revenue for fiscal year 2025, demonstrating 5% organic growth despite a dynamic operating environment m -
Bio-Techne Corp Files DEF 14A on Executive Compensation
— Sep 12, 2024 Risk: low
Bio-Techne Corp filed a DEF 14A on September 12, 2024, detailing executive compensation and corporate governance for the fiscal year ending June 30, 2024. The f
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX